We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BMS Says Probe Clears It of Illegal Conduct in Plavix Deal
BMS Says Probe Clears It of Illegal Conduct in Plavix Deal
August 25, 2006
The board of directors of Bristol-Myers Squibb (BMS) announced that an internal probe has unearthed no evidence the company engaged in illegal conduct while it and sanofi-aventis negotiated a patent settlement with Apotex over their blockbuster blood thinner Plavix.